OBJECTIVES: Lung volume reduction (LVR) is an efficient and approved treatment for selected emphysema patients. There is some evidence that repeated LVR surgery (LVRS) might be beneficial, but there are no current data on LVRS after unsuccessful bronchoscopic LVR (BLVR) with endobronchial valves (EBVs). We hypothesize good outcome of LVRS after BLVR with valves. METHODS: In this study, we retrospectively investigated all patients who underwent LVRS between 2015 and 2019 at 2 centres after previous unsuccessful EBV treatment. They were further divided into subgroups with patients who never achieved the intended improvement after BLVR (primary failure) and patients whose benefit was fading over time due to the natural development of emphysema (secondary failure). Patients with severe air leak after BLVR and immediate concomitant LVRS and fistula closure thereafter were analysed separately. RESULTS: A total of 38 patients were included. Of these, 19 patients had primary failure, 15 secondary failure and 4 were treated as an emergency due to severe air leak. At 3 months after LVRS, forced expiratory volume in 1 s had improved significantly by 12.5% (P = 0.011) and there was no 90-day mortality. Considering subgroups, patients with primary failure after BLVR seem to profit more than those with secondary failure. Patients with severe air leak after BLVR did not profit from fistula closure with concomitant LVRS. CONCLUSIONS: LVRS after previous BLVR with EBVs can provide significant clinical improvement with low morbidity, although results might not be as good as after primary LVRS.
OBJECTIVES: Lung volume reduction (LVR) is an efficient and approved treatment for selected emphysema patients. There is some evidence that repeated LVR surgery (LVRS) might be beneficial, but there are no current data on LVRS after unsuccessful bronchoscopic LVR (BLVR) with endobronchial valves (EBVs). We hypothesize good outcome of LVRS after BLVR with valves. METHODS: In this study, we retrospectively investigated all patients who underwent LVRS between 2015 and 2019 at 2 centres after previous unsuccessful EBV treatment. They were further divided into subgroups with patients who never achieved the intended improvement after BLVR (primary failure) and patients whose benefit was fading over time due to the natural development of emphysema (secondary failure). Patients with severe air leak after BLVR and immediate concomitant LVRS and fistula closure thereafter were analysed separately. RESULTS: A total of 38 patients were included. Of these, 19 patients had primary failure, 15 secondary failure and 4 were treated as an emergency due to severe air leak. At 3 months after LVRS, forced expiratory volume in 1 s had improved significantly by 12.5% (P = 0.011) and there was no 90-day mortality. Considering subgroups, patients with primary failure after BLVR seem to profit more than those with secondary failure. Patients with severe air leak after BLVR did not profit from fistula closure with concomitant LVRS. CONCLUSIONS: LVRS after previous BLVR with EBVs can provide significant clinical improvement with low morbidity, although results might not be as good as after primary LVRS.
Authors: Anna Maria Ciccone; Bryan F Meyers; Tracey J Guthrie; Gail E Davis; Roger D Yusen; Stephen S Lefrak; G Alexander Patterson; Joel D Cooper Journal: J Thorac Cardiovasc Surg Date: 2003-03 Impact factor: 5.209
Authors: Michaela Tutic; Didier Lardinois; Stephan Imfeld; Stephan Korom; Annette Boehler; Rudolf Speich; Konrad E Bloch; Erich W Russi; Walter Weder Journal: Ann Thorac Surg Date: 2006-07 Impact factor: 4.330
Authors: Wouter H van Geffen; Dirk-Jan Slebos; Felix J Herth; Samuel V Kemp; Walter Weder; Pallav L Shah Journal: Lancet Respir Med Date: 2019-02-08 Impact factor: 30.700
Authors: Frank C Sciurba; Armin Ernst; Felix J F Herth; Charlie Strange; Gerard J Criner; Charles H Marquette; Kevin L Kovitz; Richard P Chiacchierini; Jonathan Goldin; Geoffrey McLennan Journal: N Engl J Med Date: 2010-09-23 Impact factor: 91.245
Authors: Mark E Ginsburg; Byron M Thomashow; William A Bulman; Patricia A Jellen; Beth A Whippo; Cody Chiuzan; Shing Lee; Dan Bai; Joshua Sonett Journal: J Thorac Cardiovasc Surg Date: 2015-10-30 Impact factor: 5.209
Authors: Rein Posthuma; Anouk W Vaes; Kim H M Walraven; Peyman Sardari Nia; Jan U Schreiber; Hester A Gietema; Geertjan Wesseling; Emiel F M Wouters; Lowie E G W Vanfleteren Journal: Respiration Date: 2021-12-22 Impact factor: 3.966